会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明授权
    • Porous and non-porous nanostructures
    • 多孔和无孔纳米结构
    • US08568877B2
    • 2013-10-29
    • US13044250
    • 2011-03-09
    • Mauro FerrariXuewu LiuCiro ChiappiniJean Raymond Fakhoury
    • Mauro FerrariXuewu LiuCiro ChiappiniJean Raymond Fakhoury
    • H01L21/311
    • H01L29/0665B82Y10/00B82Y30/00B82Y40/00H01L2924/0002H01L2924/00
    • Disclosed are a variety of porous and non-porous wire-like structures of microscopic and nanoscopic scale. For instance, disclosed are structures that comprise a porous object that comprises: (i) a first region; and (ii) a second region adjacent to the first region along an axis of the object, where the first region has at least one porous property different from that of the second region. Also disclosed are structures that include: (i) a high resistivity silicon; and (ii) a cross-section that is substantially perpendicular to an axis of the object. Also disclosed are methods of making and using such structures. For instance, the present invention provides methods of making a porous object by: (i) obtaining an etchable substrate; (ii) forming on a surface of the substrate a patterned porosification assisting metal layer that has at least one opening; and (iii) subsequently exposing the substrate to a first etching solution and a second etching solution to form respectively a first region and a second region of a porous object.
    • 公开了各种微观和纳米尺度的多孔和无孔线状结构。 例如,公开了包括多孔物体的结构,其包括:(i)第一区域; 和(ii)沿所述物体的轴线邻近所述第一区域的第二区域,其中所述第一区域具有与所述第二区域不同的至少一个多孔性质。 还公开了包括:(i)高电阻率硅; 和(ii)基本上垂直于物体轴线的横截面。 还公开了制造和使用这种结构的方法。 例如,本发明提供了制造多孔物体的方法:(i)获得可蚀刻的基底; (ii)在所述基材的表面上形成具有至少一个开口的图案化的赋形金属层; 和(iii)随后将衬底暴露于第一蚀刻溶液和第二蚀刻溶液以分别形成多孔物体的第一区域和第二区域。
    • 5. 发明授权
    • Particles for cell targeting
    • 用于细胞靶向的粒子
    • US08563022B2
    • 2013-10-22
    • US11870077
    • 2007-10-10
    • Paolo DecuzziMauro Ferrari
    • Paolo DecuzziMauro Ferrari
    • A01N25/26A01N25/28A61K49/00
    • A61K9/1611A61K9/143A61K47/6923A61K47/6929A61K49/0002
    • Provided is a composition that includes oblate spheroidal particles comprising an active agent, such as a therapeutic or imaging agent, and a method for treating or monitoring a physiological condition, such as a disease, by administering the composition to a subject in need thereof. Also provided are methods for making particles that have a volume that can enhance the particles' adhesion to a target site in a subject's body for a pre-selected shape of the particles and methods for making particles that have a shape that can enhance particles' adhesion to a target site in a subject's body for a pre-selected volume of the particles.
    • 本发明提供一种组合物,其包含包含活性剂的扁球形颗粒,例如治疗或显像剂,以及通过将该组合物施用于有需要的受试者来治疗或监测生理状况如疾病的方法。 还提供了制备具有体积的颗粒的方法,该体积可以增强颗粒对受试者体内的靶位置的粘附性,用于颗粒的预选形状,以及用于制备具有能够增强颗粒粘附性的形状的颗粒的方法 到受试者体内的预定体积的颗粒的靶位点。
    • 10. 发明申请
    • COMBINATORIAL MULTIDOMAIN MESOPOROUS CHIPS AND A METHOD FOR FRACTIONATION, STABILIZATION, AND STORAGE OF BIOMOLECULES
    • 组合多元醇多糖和一种分解,稳定和储存生物分子的方法
    • US20110065207A1
    • 2011-03-17
    • US12839606
    • 2010-07-20
    • Mauro FerrariXuewu LiuEnnio TasciottiAli BouamraniYe Hu
    • Mauro FerrariXuewu LiuEnnio TasciottiAli BouamraniYe Hu
    • G01N33/53G01N33/00G01N33/68H01J49/26G01N30/02
    • G01N1/405G01N33/552
    • A new fractionation device shows desirable features for exploratory screening and biomarker discovery. The constituent MSCs may be tailored for desired pore sizes and surface properties and for the sequestration and enrichment of extremely low abundant protein and peptides in desired ranges of the mass/charge spectrum. The MSCs are effective in yielding reproducible extracts from complex biological samples as small as 10 μl in a time as short as 30 minutes. They are inexpensive to manufacture, and allow for scaled up production to attain the simultaneous processing of a large number of samples. The MSCs are multiplexed, label-free diagnostic tools with the potential of biological recognition moiety modification for enhanced specificity. The MSCs may store, protect and stabilize biological fluids, enabling the simplified and cost-effective collection and transportation of clinical samples. The MSC-based device may serve as a diagnostic tool to complement histopathology, imaging, and other conventional clinical techniques. The MSCs mediated identification of disease-specific protein signatures may help in the selection of personalized therapeutic combinations, in the real-time assessment of therapeutic efficacy and toxicity, and in the rational modulation of therapy based on the changes in the protein networks associated with the prognosis and the drug resistance of the disease.
    • 新的分馏装置显示出探索性筛选和生物标志物发现的理想特征。 组成的MSC可以针对所需的孔径和表面性质以及在质量/电荷谱的期望范围内极低的丰富蛋白质和肽的螯合和富集而定制。 MSCs有效地从短至30分钟的时间内将复杂的生物样品中的可重复提取物产生少至10μl。 它们制造成本便宜,并且允许放大生产以获得大量样品的同时处理。 MSCs是复合的,无标记的诊断工具,具有生物识别部分修饰的潜力,以增强特异性。 MSC可以存储,保护和稳定生物液体,从而简化和成本有效地收集和运输临床样品。 基于MSC的装置可以用作补充组织病理学,成像和其他常规临床技术的诊断工具。 MSCs介导的疾病特异性蛋白质特征的鉴定可能有助于个性化治疗组合的选择,治疗功效和毒性的实时评估,以及基于与蛋白质网络相关联的蛋白质网络的变化的合理调节治疗 预后和耐药性的疾病。